[{"address1": "550 Reserve Street", "address2": "Suite 360", "city": "Southlake", "state": "TX", "zip": "76092", "country": "United States", "phone": "682-237-7781", "website": "https://heartsciences.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Heart Test Laboratories, Inc., doing business as HeartSciences, is a medical technology company focuses on applying AI-based technology to an ECG to expand and improve an ECG's clinical utility. It is developing AI-ECG solutions, a proprietary algorithm designed to detect impaired cardiac relaxation, or cardiac dysfunction, caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG, a resting 12-lead ECG that will incorporate its AI-ECG algorithm that provides diagnostic information related to cardiac dysfunction and conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis. The company is doing business as HeartSciences. Heart Test Laboratories, Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.", "fullTimeEmployees": 15, "companyOfficers": [{"maxAge": 1, "name": "Mr. Andrew  Simpson", "age": 54, "title": "CEO, President & Chairman of the Board of Directors", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 300000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Danielle  Watson", "age": 41, "title": "CFO & Treasurer", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 179317, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark T. Hilz", "age": 64, "title": "COO, Secretary & Director", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 300000, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "maxAge": 86400, "priceHint": 4, "previousClose": 2.81, "open": 2.79, "dayLow": 2.79, "dayHigh": 3.1393, "regularMarketPreviousClose": 2.81, "regularMarketOpen": 2.79, "regularMarketDayLow": 2.79, "regularMarketDayHigh": 3.1393, "beta": 3.158, "forwardPE": -0.49125594, "volume": 17136, "regularMarketVolume": 17136, "averageVolume": 89955, "averageVolume10days": 221280, "averageDailyVolume10Day": 221280, "marketCap": 2815981, "fiftyTwoWeekLow": 2.36, "fiftyTwoWeekHigh": 52.0, "priceToSalesTrailing12Months": 151.39684, "fiftyDayAverage": 3.43796, "twoHundredDayAverage": 9.136355, "currency": "USD", "enterpriseValue": -511271, "floatShares": 822139, "sharesOutstanding": 911321, "sharesShort": 39699, "sharesShortPriorMonth": 43381, "sharesShortPreviousMonthDate": 1722384000, "dateShortInterest": 1724976000, "sharesPercentSharesOut": 0.0438, "heldPercentInsiders": 0.15957, "heldPercentInstitutions": 0.01122, "shortRatio": 1.97, "shortPercentOfFloat": 0.0442, "impliedSharesOutstanding": 911321, "bookValue": 6.546, "priceToBook": 0.472044, "lastFiscalYearEnd": 1714435200, "nextFiscalYearEnd": 1745971200, "mostRecentQuarter": 1722384000, "netIncomeToCommon": -7290042, "trailingEps": -8.41, "forwardEps": -6.29, "lastSplitFactor": "1:100", "lastSplitDate": 1715904000, "enterpriseToRevenue": -27.488, "enterpriseToEbitda": 0.073, "52WeekChange": -0.92977273, "SandP52WeekChange": 0.32258344, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "HSCS", "underlyingSymbol": "HSCS", "shortName": "Heart Test Laboratories, Inc.", "longName": "Heart Test Laboratories, Inc.", "firstTradeDateEpochUtc": 1655386200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "4248ae6b-5bf9-3528-825f-b590f53c4303", "messageBoardId": "finmb_51732680", "gmtOffSetMilliseconds": -14400000, "currentPrice": 3.09, "targetHighPrice": 15.0, "targetLowPrice": 12.0, "targetMeanPrice": 13.5, "targetMedianPrice": 13.5, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 4339778, "totalCashPerShare": 4.762, "ebitda": -7018364, "totalDebt": 1012145, "quickRatio": 3.211, "currentRatio": 4.494, "totalRevenue": 18600, "debtToEquity": 17.057, "revenuePerShare": 0.036, "returnOnAssets": -0.81688005, "returnOnEquity": -2.69291, "freeCashflow": -4563570, "operatingCashflow": -6684640, "grossMargins": 0.67306, "operatingMargins": -379.0743, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-20"}]